We believe that the cancer-promoting role of ECE2 gene is related to the modification of m6A, which may affect the methylation level of LUAD, especially HNRNPC, through its association with HNRNPC, IGF2BP1, IGF2BP3 or RBM15, and ultimately affect the progression of LUAD. The gene discussed is ECE2; the disease is cancer.